SIREN : 497585398
BIO BG is a French company founded 19 years ago, specialized in the sector Autres activités de soutien aux entreprises n.c.a.. Based in NORDHOUSE (67150), this company of category PME shows in 2021 a revenue of 5 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Revenue | 5 045 € | 3 182 € | 6 110 € | 12 220 € | 18 463 € |
| Net income | 1 784 € | -4 123 € | -3 227 € | -1 232 € | -1 249 € |
| EBITDA | 2 594 € | -1 319 € | -2 246 € | -277 € | -96 € |
| Net margin | 35.4% | -129.6% | -52.8% | -10.1% | -6.8% |
In 2021, BIO BG achieves revenue of 5 k€. Revenue is declining over the period 2017-2021 (CAGR: -27.7%). Vs 2020, growth of +59% (3 k€ -> 5 k€). After deducting consumption (0 €), gross margin stands at 5 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 3 k€, representing 51.4% of revenue. Positive scissor effect: EBITDA margin improves by +92.9 pts, sign of improved operational efficiency. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 2 k€, i.e. 35.4% of revenue. This profit can be retained or distributed to shareholders.
5 045 €
5 045 €
2 594 €
1 813 €
1 784 €
51.4%
The debt ratio (= Financial debt / Equity x 100) stands at 180%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 51%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.0 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 50.8% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
180.43%
50.686%
50.803%
0.011
In 2021, the debt ratio of BIO BG (180.43) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2021, the financial autonomy of BIO BG (50.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2021, the repayment capacity of BIO BG (0.01) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 139.40. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 1.2x. Coverage is limited: any activity downturn would jeopardize interest payments.
139.395
1.157
In 2021, the liquidity ratio of BIO BG (139.40) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2021, the interest coverage of BIO BG (1.2x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 47 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 428 days. Excellent situation: suppliers finance 381 days of the operating cycle (retail model). Overall, WCR represents 109 days of revenue, i.e. 2 k€ to permanently finance. Notable WCR improvement over the period (-34%), freeing up cash.
1 526 €
47 j
428 j
0 j
109 j
Based on 131 transactions of similar company sales (all years), the value of BIO BG is estimated at 8 012 € (range 2 512€ - 15 323€). With an EBITDA of 2 594€, the sector multiple of 4.8x is applied. The price/revenue ratio is 0.36x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 131 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare BIO BG with other companies in the same sector:
Voir toutes les statistiques du secteur Autres activités de soutien aux entreprises n.c.a.
The revenue of BIO BG in 2021 is 5 k€.
Yes, BIO BG generated a net profit of 2 k€ in 2021.
The headquarters of BIO BG is located in NORDHOUSE (67150), in the department Bas-Rhin.
The tax return of BIO BG is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
BIO BG operates in the sector Autres activités de soutien aux entreprises n.c.a. (NAF code 82.99Z). See the 'Sector positioning' section above to compare the company with its competitors.